中科生物：2023 年報

Hong Kong Stock ExchangeApr 29 06:47 ET · Announcements

Zhongke Biotech (01237) grants 3.9 million bonus shares

Zhongke Biotech (01237) issued an announcement. On April 15, 2024, in accordance with the terms of the share award plan...

Zhitong FinanceApr 15 07:07 ET

Zhongke Biotech (01237) announced annual results. Losses attributable to shareholders of 2.364 million yuan narrowed by 63.95% year-on-year

According to Zhitong Finance App, Zhongke Biotech (01237) announced its annual results for the year ended December 31, 2023. The group achieved revenue of 298 million yuan (RMB, same below), a year-on-year decrease of 36.02%; shareholders' losses of 2.364 million yuan, a year-on-year narrowing of 63.95%; the basic loss per share was 0.03 yuan; the announcement stated that in the reporting year, wood products revenue was still the Group's largest source of revenue. Revenue in this category fell 36.0% to $295 million (2022: $461 million), accounting for 99.2% of total sales for the reporting year (2022:99.1 million)

Zhitong FinanceMar 28 08:39 ET

CH ENV TECH&BIO: ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

Hong Kong Stock ExchangeMar 28 07:55 ET · Announcements

Zhongke Biotech (01237) issued a profit warning. The annual net loss is expected to decrease by about 65% year on year

Zhongke Biotech (01237) announced that the Group expects to achieve net results for the year ending December 31, 2023...

Zhitong FinanceMar 27 04:34 ET

Zhongke Biotech (01237.HK) held a board meeting on March 28 to approve annual results

Gelonghui March 15 | Zhongke Biotech (01237.HK) announced that the company will approve the annual results announcements of the company and its subsidiaries for the year ended December 31, 2023 for publication at the board meeting to be held on March 28, 2024, and is expected to implement the dividend payment proposal (if any) and handle other matters.

Gelonghui FinanceMar 15 04:41 ET